Home » Stocks » Nascent Biotech

Nascent Biotech Inc. (NBIO)

Stock Price: $0.0650 USD 0.0010 (1.56%)
Updated Oct 16, 2020 2:23 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 4.20M
Revenue (ttm) n/a
Net Income (ttm) -3.93M
Shares Out 64.56M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.0650
Previous Close $0.0640
Change ($) 0.0010
Change (%) 1.56%
Day's Open 0.0650
Day's Range 0.0610 - 0.0650
Day's Volume 87,182
52-Week Range 0.057 - 0.35

More Stats

Market Cap 4.20M
Enterprise Value 4.46M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 64.56M
Float 36.48M
EPS (basic) -0.11
EPS (diluted) -0.10
FCF / Share -0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -1.23
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 6.91
Revenue n/a
Operating Income -3.70M
Net Income -3.93M
Free Cash Flow -479,946
Net Cash -260,818
Net Cash / Share 0.00
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -80,140.20%
ROE n/a
ROIC 266.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue---3.00----
Gross Profit---3.00----
Operating Income-3.45-1.37-2.220.95-3.87-2.14-0.57-0.67
Net Income-4.00-1.37-2.221.14-4.15-2.15-1.92-0.69
Shares Outstanding34.3930.0925.8821.8019.7713.993.152.69
Earnings Per Share-0.12-0.05-0.090.05-0.21-0.15-0.61-0.26
Operating Cash Flow-0.55-0.71-1.22-0.77-0.17-0.47-0.13-0.09
Free Cash Flow-0.55-0.71-1.22-0.77-0.17-0.47-0.13-0.09
Cash & Equivalents0.000.130.120.130.570.110.110.00
Total Debt0.14----0.06-0.15
Net Cash / Debt-0.140.130.120.130.570.050.11-0.15
Assets-0.130.120.901.400.940.120.01
Liabilities2.880.610.200.172.973.141.571.95
Book Value-2.88-0.48-0.090.73-1.57-2.21-1.45-1.95
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nascent Biotech Inc.
Country United States
CEO Sean Carrick

Stock Information

Ticker Symbol NBIO
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: NBIO

Description

Nascent Biotech, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer. The company has a research collaboration agreement with Manhattan BioSolutions, Inc. to initiate a vaccine program for the prevention of COVID-19 or other viral infections; and a collaboration with Hoag Family Cancer Institute and Pickup Family Neurosciences Institute for the testing of antibody brain cancer drug. The company is based in San Diego, California.